Table 2.
Variable | Category |
||||
---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | |
Nonoperative treatment option effectiveness∗ | None available | Available, < 40% as effective as operation |
Available, 40% to < 60% as effective as operation | Available, 60% to < 95% as effective as operation | Available, ≥ 95% or equally effective |
Nonoperative treatment option resource use/exposure risk | Significantly worse/not applicable | Somewhat worse | Equivalent | Somewhat better | Significantly Better |
Impact of 2-wk delay in disease outcomes | Significantly worse | Worse | Moderately worse | Slightly worse | No worse |
Impact of 2-wk delay in surgical difficulty/risk | Significantly worse | Worse | Moderately worse | Slightly worse | No worse |
Impact of 6-wk delay in disease outcomes | Significantly worse | Worse | Moderately worse | Slightly worse | No worse |
Impact of 6-wk delay in surgical difficulty/risk | Significantly worse | Worse | Moderately worse | Slightly worse | No worse |
Disease score 6 to 30. Higher score equates with less harm to patient if nonoperative treatment is pursued and/or operation delayed. Limited resources might be better deployed for diseases where nonoperative treatment is less effective or not available, or delayed surgical treatment leads to worse disease outcomes and/or increases surgical risk. Consideration of disease factors at 2 different time points integrates natural history of disease, significance of patient symptoms, and time sensitivity of operation into the decision-making process.
Patients scoring 1 point under “nonoperative treatment option effectiveness” will also score 1 point under “nonoperative treatment option resource use/exposure risk” because the question would be “not applicable.”